Citius Pharmaceuticals, Inc. (CTXR) › Net IncomeCitius Pharmaceuticals, Inc. (CTXR) — Net IncomeAnnual figures by fiscal year, from SEC filings.2017: -$10.38M2018: -$12.54M2019: -$15.56M2020: -$17.55M2021: -$23.05M2022: -$33.64M2023: -$32.54M2024: -$39.43M2025: -$39.74M-$39.74M2017Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$39.74M-0.8%2024-$39.43M-21.2%2023-$32.54M+3.3%2022-$33.64M-45.9%2021-$23.05M-31.4%2020-$17.55M-12.8%2019-$15.56M-24.1%2018-$12.54M-20.7%2017-$10.38M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share